USA - engelsk - NLM (National Library of Medicine)

jiangsu hengrui pharmaceuticals co., ltd. - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 100 mg - gabapentin capsules is indicated for: - management of postherpetic neuralgia in adults - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin, during pregnancy. encourage women who are taking gabapentin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of gabapentin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally tox

USA - engelsk - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - daptomycin (unii: nwq5n31vkk) (daptomycin - unii:nwq5n31vkk) - daptomycin for injection is indicated for the treatment of adult patients with complicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only). pediatric use information is approved for merck & co., inc.’s cubicin (daptomycin for injection). however, due to merck & co., inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. daptomycin for injection is indicated for the treatment of adult patients with staphylococcus aureus bloodstream infections (bacteremia), including adult patients with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates. pediatric use information is approved for merck & co., inc.’s cubicin (daptomyci

Ecuador - spansk - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

jiangsu hengrui medicine co. ltd. china - dexmedetomidina clorhidrato 236 mcg (equivalente a dexmedetomidina 200 mcg) - solucion inyectable - cada vial de 2 ml contiene: dexmedetomidina clorhidrato 236 mcg (equivalente a dexmedetomidina 200 mcg)

Ecuador - spansk - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

jiangsu hengrui medicine co. ltd. china - cisatracurio besilato 13,38 mg (equivalente a cisatracurio 10 mg) - solucion inyectable - cada vial de 5 ml contiene: cisatracurio besilato 13,38 mg (equivalente a cisatracurio 10 mg)

Ecuador - spansk - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

jiangsu hengrui medicine co. ltd. china - cada ml contiene: dexmedetomidina hcl 4,72 mcg equivalente a dexmedetomidina 4 mcg - solucion inyectable - cada ml contiene: dexmedetomidina hcl 4,72 mcg equivalente a dexmedetomidina 4 mcg

Ecuador - spansk - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

jiangsu hengrui medicine co. ltd. china - cada vial contiene: acetato de caspofungina 55,5 mg equivalente a caspofungina 50 mg - polvo concentrado para solucion inyectable para perfusion - cada vial contiene: acetato de caspofungina 55,5 mg equivalente a caspofungina 50 mg

Ecuador - spansk - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

jiangsu hengrui medicine co. ltd. china - cada vial contiene: acetato de caspofungina 77,7 mg equivalente a caspofungina 70 mg - polvo concentrado para solucion inyectable para perfusion - cada vial contiene: acetato de caspofungina 77,7 mg equivalente a caspofungina 70 mg

USA - engelsk - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium 2 mg in 1 ml - cisatracurium besylate injection is indicated: - as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age - to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the icu - to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older limitations of use cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. cisatracurium besylate injection is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium have been reported [see warnings and precautions ( 5.4)] . the use of 10 ml cisatracurium multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth-weight infants because the formulation contains benzyl alcohol [see warnings and

USA - engelsk - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium 2 mg in 1 ml - cisatracurium besylate injection is indicated: - as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age - to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the icu - to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older limitations of use cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. cisatracurium besylate injection is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium have been reported [see warnings and precautions ( 5.4)] . the use of 10 ml cisatracurium multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth-weight infants because the formulation contains benzyl alcohol [see warnings and

USA - engelsk - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 100 ug in 1 ml - dexmedetomidine injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. dexmedetomidine injection should be administered by continuous infusion not to exceed 24 hours. dexmedetomidine injection has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. it is not necessary to discontinue dexmedetomidine injection prior to extubation. dexmedetomidine injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. none. pregnancy category c there are no adequate and well-controlled studies of dexmedetomidine use in pregnant women. in an in vitro human placenta study, placental transfer of dexmedetomidine occurred. in a study in the pregnant rat, placental transfer of dexmedetomidine was observed when radiolabeled dexmedetomidine was administered subcutaneously. thus, fetal exposure should be expected in human